featured
Dr. Robert Brodell on the Top Ten PracticeChangers in 2015 in Dermatology
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
-
Saul K, Casamiquela K, McCowan NK, Brodell RT, Jackson JD. Embracing Clinical Learning Environment Review (CLER) in a Dermatology Residency Training Program. Cutis. Accepted July 28, 2015.
- Wu X, Elkin EB, Jason Chen CS, Marghoob A. Traditional versus streamlined management of basal cell carcinoma (BCC): A cost analysis. J Am Acad Dermatol. 2015;73(5):791-798.
- Ren Z, Zhu K, Kang H, et al. Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2015;33(8):894-900.
- Hofheinz RD, Gencer D, Schulz H, et al. Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group. J Clin Oncol. 2015;33(22):2444-2449.
- Maley A, Swerlick RA. Azathioprine treatment of intractable pruritus: A retrospective review. J Am Acad Dermatol. 2015;73(3):439-443.
- Cosulich MT, Molenda MA, Mostow E, Bhatia AC, Brodell RT. Minimal incision extraction of lipomas. JAMA Dermatol. 2014;150(12):1360-1361.
- Kindley KJ, Jackson JD, Sisson WT, Brodell RT. Improving Dermatology Clinical Efficiency in Academic Medical Centers. Int J Health Science. 2015;9:3(10).
- Feder HM Jr, N Bennett, JF Modlin. Atypical hand, foot, and mouth disease: a vesiculobullous eruption caused by Coxsackie virus A6. Lancet Infect Dis. 2014;14(1):83-86.
- Mathes EF, Oza V, Frieden IJ, et al. "Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics. 2013;132(1):e149-e157.
- Taieb A, Ortonne JP, Ruzicka T, et al. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol. 2015;172(4):1103-1110.
- Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453-1460.
Disclosure statements are available on the authors' profiles: